| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/23/1999 | US5874611 A chemical intermediate for chroman derivatives useful as a blood sugar-lowering agent |
| 02/23/1999 | US5874595 Single step, selective acetylation of 10-deacetylbaccatin iii into baccatin iii using lewis acid catalysts in the reaction with acetic anhydride; preparation of taxol from baccatin iii |
| 02/23/1999 | US5874591 Method for the preparation of (±)-calanolide A and intermediates thereof |
| 02/23/1999 | US5874583 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/23/1999 | US5874578 Reacting purine salt with bis(2,3-protected hydroxymethyl)cyclobutane |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874567 Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
| 02/23/1999 | US5874566 Il-15 triplex oligonucleotides |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874530 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process |
| 02/23/1999 | US5874478 Antiviral agents |
| 02/23/1999 | US5874477 Method of treatment for malaria utilizing serotonin receptor ligands |
| 02/23/1999 | US5874474 Topical application for relief of adverse skin condition for animals |
| 02/23/1999 | US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| 02/23/1999 | US5874472 Aminoacid derivatives as no synthase inhibitors |
| 02/23/1999 | US5874471 Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
| 02/23/1999 | US5874470 Isotonic fat emulsion containing omega-3-fatty acids and use thereof |
| 02/23/1999 | US5874468 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 02/23/1999 | US5874463 Mixture of kojic acid, salicyclic acid and alpha-hydroxy acid; facial skin exfoliation |
| 02/23/1999 | US5874462 Use of substituted 6-amino-4H-pyrans |
| 02/23/1999 | US5874461 Use of Nebivolol as an anti-atherogenic |
| 02/23/1999 | US5874460 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
| 02/23/1999 | US5874458 Psychological disorders |
| 02/23/1999 | US5874457 Imidazolylalkyl derivatives of imidazo 1,5-a!indol-3-one |
| 02/23/1999 | US5874455 Method for treatment of cataract with radical scavenger |
| 02/23/1999 | US5874454 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 02/23/1999 | US5874451 Hypolipidemic agents |
| 02/23/1999 | US5874450 Aqueous buffered solution having alkaline ph containing a sleep promoting amount of doxylamine and anionic surfactants selected from long chain hydrocarbon sulfonates or carboxylates |
| 02/23/1999 | US5874449 Inhibitors of immunophilin |
| 02/23/1999 | US5874447 High purity organosulfonate salt of paroxetine with excellent stability, solubility; react with a base to make high purity paroxetine, or with a reagent to make the high purity salt of said reagent (ex: paroxetine maleate from maleic acid) |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874444 Poly (ADP-ribose) polymerase inhibitors to treat diseases associated with cellular senescence |
| 02/23/1999 | US5874441 Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
| 02/23/1999 | US5874440 Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives |
| 02/23/1999 | US5874437 Impotence |
| 02/23/1999 | US5874436 Effective in inhibiting the action of a bacterial histidine protein kinase; useful against antibiotic resistant organisms |
| 02/23/1999 | US5874435 Psychological disorders; analgesics |
| 02/23/1999 | US5874434 10,11-methanodibenzosuberane derivatives |
| 02/23/1999 | US5874433 Treating prophylaxis or hypotension induced by cytokine therapy or exposure to bacterial endotoxin by administering a nitric oxide synthase inhibitor |
| 02/23/1999 | US5874432 Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 02/23/1999 | US5874431 Benzazole compounds |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/23/1999 | US5874427 Substituted heteroaromatic 5-HT1F agonists |
| 02/23/1999 | US5874426 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 02/23/1999 | US5874422 Reducing the drug side-effect while treating cardiovascular system disorder |
| 02/23/1999 | US5874421 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 02/23/1999 | US5874420 Process for regulating vagal tone |
| 02/23/1999 | US5874419 Compositions and methods for modulating growth of a tissue in a mammal |
| 02/23/1999 | US5874413 Cytomegalo virus |
| 02/23/1999 | US5874412 Anticancer agents |
| 02/23/1999 | US5874402 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874118 Adding urea, trimethylamine oxide to standard feed; salt water fish |
| 02/23/1999 | US5874107 Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent |
| 02/23/1999 | US5874104 Treatment of systemic fungal infections with phospholipid particles encapsulating polyene antibiotics |
| 02/23/1999 | US5874103 Dosage consists of an ionophore antibiotic, wetting agent or surfactant, antifreeze agent, suspension agent and water; orally administered to an animal to treat ketosis and/or bloat; enhancement of milk and milk protein |
| 02/23/1999 | US5874095 Pharmaceutical active material, non-ionic crosslinked polyacrylamide having a molecular weight of from 1,000,000 to 30,000,000, the polyacrylamide being predispersed in a water-immiscible oil containing a surfactant |
| 02/23/1999 | US5874090 Sustained-release formulation of methylphenidate |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | US5874064 Aerodynamically light particles for pulmonary drug delivery |
| 02/23/1999 | US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma |
| 02/23/1999 | CA2176255C Isoxazoline compounds as antiinflammatory agents |
| 02/23/1999 | CA2168265C Antidepressant |
| 02/23/1999 | CA2146007C Substituted quinuclidines |
| 02/23/1999 | CA2136801C Pharmaceutical agents for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria |
| 02/23/1999 | CA2133594C Process of preparing etoposide phosphate and etoposide |
| 02/23/1999 | CA2129919C Pharmaceutical composition having antiviral and antibacterial activity and method of administration |
| 02/23/1999 | CA2123992C Composition containing body activated fragrance for contacting the skin and method of use |
| 02/23/1999 | CA2120538C Use of bisphosphonic acid derivatives for promoting bone repair and corresponding drugs |
| 02/23/1999 | CA2100269C Use of 1, 3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 02/23/1999 | CA2087805C Immuno-suppressing agent |
| 02/23/1999 | CA2011143C Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| 02/23/1999 | CA1340402C Quinoline derivatives and processes for preparation thereof |
| 02/22/1999 | CA2245331A1 Pharmaceutical compounds |
| 02/21/1999 | CA2245314A1 Method for removal of residual organic solvents and use thereof in maufacturing pharmaceuticals |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2245095A1 Method for treating heart failure |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 02/18/1999 | WO1999007856A1 Novel metalloprotease |
| 02/18/1999 | WO1999007743A1 Method for the continuous production of hydrolytically broken down and possibly substituted starch, use of hydrolytically broken down starch and device for producing same |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007734A2 Hepatitis c inhibitor peptide analogues |
| 02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | WO1999007721A1 Improved process for antiparasitic agent |
| 02/18/1999 | WO1999007720A2 Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes |
| 02/18/1999 | WO1999007718A2 Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same |